These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9508351)

  • 21. Liver veno-occlusive disease after bone marrow transplantation changes in coagulation parameters and endothelial markers.
    Scrobohaci ML; Drouet L; Monem-Mansi A; Devergie A; Baudin B; D'Agay MF; Gluckman E
    Thromb Res; 1991 Sep; 63(5):509-19. PubMed ID: 1755004
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Laboratory markers of veno-occlusive disease in the course of bone marrow and subsequent liver transplantation.
    Salat C; Holler E; Wolf C; Kolb HJ; Reinhardt B; Pihusch R; Krämling HJ; Heinemann V; Haller M; Hiller E
    Bone Marrow Transplant; 1997 Mar; 19(5):487-90. PubMed ID: 9052916
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The relevance of plasminogen activator inhibitor 1 (PAI-1) as a marker for the diagnosis of hepatic veno-occlusive disease in patients after bone marrow transplantation.
    Salat C; Holler E; Kolb HJ; Pihusch R; Reinhardt B; Penovici M; Ledderose G; Hiller E
    Leuk Lymphoma; 1999 Mar; 33(1-2):25-32. PubMed ID: 10194118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decreased incidence of hepatic veno-occlusive disease and fewer hemostatic derangements associated with intravenous busulfan vs oral busulfan in adults conditioned with busulfan + cyclophosphamide for allogeneic bone marrow transplantation.
    Lee JH; Choi SJ; Lee JH; Kim SE; Park CJ; Chi HS; Lee MS; Lee JS; Kim WK; Lee KH
    Ann Hematol; 2005 May; 84(5):321-30. PubMed ID: 15580502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma thrombopoietin levels in marrow transplant patients with veno-occlusive disease of the liver.
    Oh H; Tahara T; Bouvier M; Farrand A; McDonald GB
    Bone Marrow Transplant; 1998 Oct; 22(7):675-9. PubMed ID: 9818695
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in protein C, factor VII and endothelial markers after autologous bone marrow transplantation: possible implications in the pathogenesis of veno-occlusive disease.
    Bazarbachi A; Scrobohaci ML; Gisselbrecht C; Marolleau JP; Mansi A; Brice P; Gorra P; Drouet L
    Nouv Rev Fr Hematol (1978); 1993 Apr; 35(2):135-40. PubMed ID: 8332449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A trial use of prostaglandin E1 for prevention of hepatic veno-occlusive disease after allogeneic bone marrow transplantation].
    Morio S; Oh H; Kogure K; Ishii H; Ishii A; Nakaseko C; Ikegami T; Kawano E; Matsuura Y; Nishimura M
    Rinsho Ketsueki; 1994 Sep; 35(9):846-52. PubMed ID: 7967053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of pulmonary function testing abnormalities and severe veno-occlusive disease of the liver after marrow transplantation.
    Matute-Bello G; McDonald GD; Hinds MS; Schoch HG; Crawford SW
    Bone Marrow Transplant; 1998 Jun; 21(11):1125-30. PubMed ID: 9645575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Orthotopic liver transplantation for life-threatening veno-occlusive disease of the liver after allogeneic bone marrow transplant.
    Rapoport AP; Doyle HR; Starzl T; Rowe JM; Doeblin T; DiPersio JF
    Bone Marrow Transplant; 1991 Nov; 8(5):421-4. PubMed ID: 1768978
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasminogen activator inhibitor-1 is an independent diagnostic marker as well as severity predictor of hepatic veno-occlusive disease after allogeneic bone marrow transplantation in adults conditioned with busulphan and cyclophosphamide.
    Lee JH; Lee KH; Lee JH; Kim S; Seol M; Park CJ; Chi HS; Kang W; Kim ST; Kim WK; Lee JS
    Br J Haematol; 2002 Sep; 118(4):1087-94. PubMed ID: 12199790
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Related donor liver transplant for veno-occlusive disease following T-depleted unrelated donor bone marrow transplantation.
    Bunin N; Leahey A; Dunn S
    Transplantation; 1996 Feb; 61(4):664-6. PubMed ID: 8610401
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravenous immunoglobulin and the risk of hepatic veno-occlusive disease after bone marrow transplantation.
    Sullivan KM; Kansu E; Storer B; Jocom J; Emerson G; Reagan T; Emerson V; Siadak MF; Davis C; Appelbaum FR; Buckner CD; Hansen JA; Shulman HM; Storb R; McDonald GB
    Biol Blood Marrow Transplant; 1998; 4(1):20-6. PubMed ID: 9701388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Homocysteine and prothrombin fragment 1+2 levels in patients with veno-occlusive disease after stem cell transplantation.
    Gerecitano J; Mathias C; Mick R; Duffy KM; Luger S; Stadtmauer EA; Schuster SJ; Tsai D; Nasta S; Berlin J; Phillips DK; High KA; Porter DL
    J Hematother Stem Cell Res; 2003 Apr; 12(2):215-23. PubMed ID: 12804180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of clinical criteria for the diagnosis of veno-occlusive disease of the liver after bone marrow transplantation.
    Blostein MD; Paltiel OB; Thibault A; Rybka WB
    Bone Marrow Transplant; 1992 Nov; 10(5):439-43. PubMed ID: 1464007
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemostatic complications in bone marrow transplantation: a retrospective analysis of 447 patients.
    Pihusch R; Salat C; Schmidt E; Göhring P; Pihusch M; Hiller E; Holler E; Kolb HJ
    Transplantation; 2002 Nov; 74(9):1303-9. PubMed ID: 12451270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frequency of veno-occlusive disease of the liver in bone marrow transplantation with a modified busulfan/cyclophosphamide preparative regimen.
    Brodsky R; Topolsky D; Crilley P; Bulova S; Brodsky I
    Am J Clin Oncol; 1990 Jun; 13(3):221-5. PubMed ID: 2346127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recombinant tissue plasminogen activator (rt-PA) for veno-occlusive liver disease in pediatric autologous bone marrow transplant patients.
    Yu LC; Malkani I; Regueira O; Ode DL; Warrier RP
    Am J Hematol; 1994 Jul; 46(3):194-8. PubMed ID: 8192148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatic venoocclusive disease in blood and bone marrow transplantation in children and young adults: incidence, risk factors, and outcome in a cohort of 241 patients.
    Reiss U; Cowan M; McMillan A; Horn B
    J Pediatr Hematol Oncol; 2002 Dec; 24(9):746-50. PubMed ID: 12468917
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction of veno-occlusive disease using biomarkers of endothelial injury.
    Cutler C; Kim HT; Ayanian S; Bradwin G; Revta C; Aldridge J; Ho V; Alyea E; Koreth J; Armand P; Soiffer R; Ritz J; Richardson PG; Antin JH
    Biol Blood Marrow Transplant; 2010 Aug; 16(8):1180-5. PubMed ID: 20184961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Veno-occlusive disease of the liver].
    Rybicka M; Krysiak R; Okopień B
    Wiad Lek; 2009; 62(1):42-51. PubMed ID: 19817257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.